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Summary
Background Nine potentially modifiable risk factors (less childhood education, midlife hearing loss, hypertension, 
and obesity, and later-life smoking, depression, physical inactivity, social isolation, and diabetes) account for 35% of 
worldwide dementia, but most data to calculate these risk factors come from high-income countries only. We aimed 
to calculate population attributable fractions (PAFs) for dementia in selected low-income and middle-income 
countries (LMICs) to identify potential dementia prevention targets in these countries.
Methods The study was an analysis of cross-sectional data obtained from the 10/66 Dementia Research surveys of 
representative populations in India, China, and six Latin America countries (Cuba, Dominican Republic, Mexico, 
Peru, Puerto Rico, and Venezuela), which used identical risk factor ascertainment methods in each country. Between 
2004 and 2006 (and between 2007 and 2010 for Puerto Rico), all residents aged 65 years and older in predefined 
catchment areas were invited to participate in the survey. We used risk factor prevalence estimates from this 
10/66 survey data, and relative risk estimates from previous meta-analyses, to calculate PAFs for each risk factor. To 
account for individuals having overlapping risk factors, we adjusted PAF for communality between risk factors, and 
used these values to calculate overall weighted PAFs for India, China, and the Latin American sample.
Findings The overall weighted PAF for potentially modifiable risk factors for dementia was 39·5% (95% CI 37·5–41·6) 
in China (n=2162 participants), 41·2% (39·1–43·4) in India (n=2004), and 55·8% (54·9–56·7) in our Latin American 
sample (n=12 865). Five dementia risk factors were more prevalent in these LMICs than worldwide estimates, leading 
to higher PAFs for dementia: less childhood education (weighted PAF of 10·8% in China, 13·6% in India, and 
10·9% in Latin America vs 7·5% worldwide), smoking (14·7%, 6·4%, and 5·7%, respectively, vs 5·5% worldwide), 
hypertension (6·4%, 4·0%, and 9·3%, vs 2·0%), obesity (5·6%, 2·9%, and 7·9%, vs 0·8%), and diabetes (1·6%, 
1·7%, and 3·2%, vs 1·2%).
Interpretation The dementia prevention potential in India, China, and this sample of Latin American countries is 
large, and greater than in high-income countries. Less education in early life, hypertension, hearing loss, obesity, and 
physical inactivity have particularly high PAFs and could be initial targets for dementia prevention strategies.
Funding No funding.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
4.0 license.
Introduction
Around two thirds of people with dementia worldwide live 
in low-income and middle-income countries (LMICs). The 
number of people with dementia in these countries is 
predicted to rise more rapidly than in higher-income 
countries because an increasing number of people in 
LMICs are living to an older age.1 However, potentially 
modifiable risk factors for dementia might drive or moder-
ate this increase, as they have in many higher-income 
countries where falling age-specific dementia incidence 
and prevalence have been reported,2,3 related to higher 
levels of education4 and reduced cardiovascular morbidity.5
Population attributable fractions (PAFs) estimate the 
proportion of disease cases that would not occur in a 
population if an individual risk factor were to be eliminated. 
We previously reported the overall PAF for dementia using 
the nine potentially modifiable risk factors for dementia 
that had been identified by the UK National Institute 
for Health and Care Excellence6 and the US National 
Institutes of Health.7 We found that 35% (95% CI 
34·1–35·9) of dementia was theoretically preventable 
through elimination of these risk factors;2 namely, less 
education in childhood, hearing loss, hypertension, obesity 
in midlife (age 45–64 years), depression, social isolation, 
physical inactivity, diabetes, and smoking in later life (age 
>65 years). To calculate this percentage, we used meta-
analyses of relative risk (RR) for dementia associated with 
each risk factor and prevalence of that risk based on 
summary global prevalence estimates,8 which were studied 
predominantly in high-income countries. Whether PAF 
estimates are applicable to LMICs is therefore unclear, 
given that the prevalence of some risk factors are likely to 
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differ in these regions because of different educational 
policies, health behaviours, genetic predisposition, and 
health-care practice. PAF in LMICs might therefore be 
higher or lower than in high-income countries, resulting 
in specific priority targets for dementia prevention in 
particular countries. In this study, we aimed to estimate the 
PAF of potentially modifiable risk factors for dementia in 
LMICs for which we could obtain population-level data.
Methods
Data
The study was an analysis of cross-sectional data 
obtained from the 10/66 Dementia Research Group 
comprehensive one-phase prevalence surveys,9 given 
that these surveys reported data on the nine identified 
potentially modifiable risk factors for dementia. The 
10/66 Dementia Research Group aimed to interview all 
residents aged at least 65 years in geographically 
defined catchment areas in selected LMICs, and used 
cross-culturally validated assessments for dementia.9 
Participants were inter viewed between 2004 and 2006 
(and between 2007 and 2010 in Puerto Rico). These data 
are available for 17 031 participants in eight countries 
(Cuba, Dominican Republic, Mexico, Peru, Puerto Rico 
and Venezuela [grouped hereafter as the Latin American 
sample]; China; and India). Sample size varied between 
1900 and 3000 for each country and more than 80% of 
the target population responded in all areas surveyed.
Risk factor prevalence
We calculated prevalence for the risk factors of interest 
using 10/66 Dementia Research Group data,9 aiming 
to group them into early-life (age <45 years), midlife 
(age 45–64 years), and later-life (age ≥65 years) risk factors 
on the basis of previous literature10 that linked these 
factors to these particular age groups. Definitions of each 
risk factor are presented in panel 1. We dealt with missing 
data by case-wise deletion given that the proportion of 
missing data was very low (0–2%) for all variables, except 
social contact, which had 10–12·7% missing data.
Some factors that are risks in middle age (eg, hyper-
tension and obesity) decrease before the onset of dementia 
as part of the developing illness, and therefore attributing 
risk factors to specific time periods within the lifecourse 
is essential.2 However, for hypertension and obesity, 
prevalence data for midlife were not available. We there-
fore used the prevalence of pre-existing hypertension 
and obesity at the time of the survey as an estimate of mid-
life prevalence. Although the 10/66 Dementia Research 
Group sample contained individuals who were older than 
65 years, 60% of those were younger than 75 years, and so 
for a substantial proportion of the sample, the diagnosis of 
hypertension and the development of obesity are likely to 
have occurred during midlife. Obesity was measured by 
waist circumference (which is con sidered to be a more 
valid measure of obesity-related risk than body-mass 
index)13 and was favoured over waist-to-hip ratio because of 
the relative ease of obtaining this measurement.11
The PAF for a risk factor is defined as the percentage of 
cases of a disease that would be eliminated if that 
particular risk factor was eliminated. The value of the 
PAF depends on the prevalence of the risk factor and the 
strength of its association (RR) with the disease.
Statistical analysis
We calculated the prevalence estimates of the nine risk 
factors for each of the eight countries using 
10/66 Dementia Research Group data. Given that the 
prevalence estimates were similar in each Latin 
American country, we grouped these into one estimate 
for the Latin American sample by calculating the 
prevalence from the combined data. As in our previous 
Research in context
Evidence before this study
We searched PubMed on March 21, 2018, for any studies 
investigating population attributable fractions (PAFs) or 
preventable dementia in low-income and middle-income 
countries (LMICs) using the search terms “dementia”, 
“preventable”, and “low income”, with no limits on language or 
date of publication. We found no papers investigating overall 
dementia risk, although there were some articles investigating 
individual risk factors and their link with dementia in LMICs. 
We have previously published estimates of PAFs for dementia 
risk factors based on worldwide prevalence estimates from 
meta-analyses (primarily those that included studies from 
higher-income countries), and found that up to 35% of 
dementia cases are potentially preventable worldwide.
Added value of this study
We used data from the 10/66 Dementia Research Group from 
eight LMICs to estimate the prevalence of nine risk factors for 
dementia and then we calculated the percentage of potentially 
preventable dementia cases in these regions. To the best of 
our knowledge, this is the first such calculation. We searched 
the literature for other studies of risk factor prevalence for 
dementia and used the studies with the highest and lowest 
prevalence estimates in sensitivity analyses to calculate 
highest and lowest possible PAF estimates.
Implications of all the available evidence
The PAF percentage is higher in India, China, and our 
Latin American sample of countries than worldwide estimates, 
indicating greater potential for dementia prevention in these 
regions. Low education was the risk factor with the highest 
PAF in all three regions, but other priority risk factors are 
hypertension in China and Latin America and smoking in India.
For more on the 10/66 Dementia 
Research Group see 
https://www.alz.co.uk/1066/
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study, we used previously published meta-analyses of 
RR for individual risk factors.8 We then adjusted the 
results for com munality (ie, overlap between risk 
factors).
The formula used to calculate PAF is available in 
panel 2. We chose to use RRs for risk factors on the basis 
of previous meta-analyses.2,8,10 Details of how we 
calculated overall PAF are shown in panel 2. People 
might have several risk factors and individual PAFs 
cannot therefore be summed to get the total PAF; thus, it 
is important to consider communality and to calculate a 
weighted PAF, taking communality into account. 
Individual weighted PAFs were calculated with the 
following formula: 
We did sensitivity analyses to estimate variability in 
PAF depending on prevalence of each risk factor, 
by using estimates from other high-quality studies 
(appendix) of risk factor prevalence. We did a literature 
search in PubMed for articles published from database 
inception to June 8, 2018, using the search terms for 
each risk factor, the country or region of interest, and the 
age group of interest—eg, “China”, “older adults”, and 
“hypertension” or “high blood pressure”. We did not 
restrict our searches by language or date of publication. 
In line with guidance14  for evaluating prevalence 
studies, we defined a prevalence study as one that used 
probability sampling with at least 70% response and 
reported a prevalence for the specified risk factor from 
the relevant countries, using valid tools for measuring 
each risk factor.14 We used the lowest and highest 
prevalence figures found to calculate possible lowest and 
highest PAFs. In cases in which we found no differing 
prevalence estimates for a specific risk factor from 
population surveys, we used 10/66 Dementia Research 
Group prevalence figures in the sensitivity analyses to 
calculate the overall PAF. Therefore, in these calculations 
the weighted prevalence still changed in our sensitivity 
analyses despite using the same prevalence figures, 
Panel 1: Definitions of risk factors from 10/66 Dementia 
Research Group data9
Less education




Self-reported known diagnosis of hypertension
Obesity
Waist circumference measured by the 10/66 research team, 
of at least 88 cm in women and more than 102 cm in men, 
according to WHO guidelines11
Smoking
Self-reported smoking in later life
Depression
Diagnosis of depression (according to the fourth edition of 
the Diagnostics and Statistical Manual of Mental Disorders) in 
later life following a structured Geriatric Mental State12 
interview or self-report of previous depression
Physical inactivity
Self-report of being either not at all or not very physically 
active in later life on a four-point Likert scale of level of physical 
activity (categories are not at all, not very, fairly, and very 
physically active)
Social isolation
Social contact occurring less than once per month in later life,2 
calculated using pooled self-reported contact frequency with 
friends, relatives, and neighbours or attendance at social clubs
Diabetes
Self-report of known diagnosis of diabetes in later life
Panel 2: Standard method for the calculation of population attributable fractions and 
communality10
Formula for individual population attributable fraction
Population attributable fraction (PAF)=Pe(RRe – 1) / (1 + Pe[RRe – 1]), in which Pe is the 
prevalence of the exposure and RRe the relative risk of disease because of that exposure.
Calculation of communality
Input data for all nine risk factors into our model.
Calculate the tetrachoric correlation to generate correlation coefficients and a correlation 
matrix. This calculation establishes the correlation between unobserved and latent 
variables and observed dichotomous variables.
Do a principal component analysis on the correlation matrix to generate eigenvectors, 
which are directions mapped onto the datapoints from which variance to the data is 
measured. These eigenvectors represent unobserved factors underlying all the variables 
that explain the variance observed.
Components with eigenvalues of at least 1 were retained in the model, as is standard 
practice, so that only eigenvectors that hold the most information about the data 
distribution are retained.
Communality was calculated as the sum of the square of all factor loadings (ie, how much 
each unobserved component explained each measured variable).
Calculation of overall PAF
We then calculated overall PAF:
PAF=1 – [(1 – PAF1)(1 – PAF2)(1 – PAF3)…]
Each individual risk factor’s PAF was weighted according to its communality using the 
formula:
Weight (w)=1 – communality
Weighting was included in the calculation of overall PAF using the formula:
PAF=1 – [(1 – w*PAF1)(1 – w*PAF2)(1 – w*PAF3)...]
individual weighted PAF= 
∑
 





e599 www.thelancet.com/lancetgh   Vol 7   May 2019
because of the weighting adjustment. If other factors 
were less prevalent, then a risk factor with unchanged 
prevalence contributed a relatively larger risk to the 
overall PAF (and the inverse for the highest PAF 
estimate).
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing 
of the report. The corresponding author had full access 
to all the data in the study and had final responsibility 
for the decision to submit for publication.
Results
In this analysis, we used data from 12 865 respondents in 
Latin America, 2162 respondents in China, and 2004 
respondents in India to calculate PAFs. The median age 
was 73 years (range 65 to 110) and 62·5% of the sample 
was female.
The proportion of dementia cases that were theoretically 
preventable through elimination of the nine identified 
risk factors (ie, overall weighted PAF) was 55·8% (95% CI 
54·9–56·7) in Latin America, 39·5% (37·5–41·6) in 
China, and 41·2% (39·1–43·4) in India (figure). Risk 
factor prevalence, communality, and weighted PAFs 
for each region are presented in tables 1–3. For 
comparison, the previously published worldwide risk 
factor prevalence, communality, and weighted PAF are 
presented in table 4. We have provided risk factor 
prevalence esti mates for each individual Latin American 
country and the associated PAFs in the appendix. The 
PAFs for the Latin American countries in our sample 
were: 52·7 (95% CI 50·9–54·5) for Cuba, 54·3 (52·1–56·4) 
for the Dominican Republic, 50·2 (47·9–52·4) for Peru, 
54·8 (52·6–57·0) for Venezuela, 55·5 (53·5–57·7) for 
Mexico, and 53·2 (50·9–55·3) for Puerto Rico. Less 
childhood education, smoking, hypertension, obesity, and 
diabetes were more common than worldwide estimates 
across all three regions, leading to higher PAF.
Figure: Population attributable fractions for potentially modifiable risk factors in low-income and middle-income countries
*Our data for Latin America include the data for Cuba, Dominican Republic, Mexico, Peru, Puerto Rico, and Venezuela.
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Overall weighted PAF ·· ·· ·· ·· 39·5% 
(37·5–41·6)
PAF=population attributable fraction. RR=relative risk. *Weighted PAF is the relative contribution of each risk factor to 
the overall PAF when adjusted for communality. 
Table 1: PAF for dementia risk factors in China (n=2162)
See Online for appendix
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The range of estimates for the overall PAF combining 
all nine risk factors and using highest and lowest risk 
factor prevalence estimates was 31–55% in China, 
34–45% in India, and 44–58% in the Latin American 
sample. In particular, we found a trend for better 
educational attainment over time, which reduces the 
PAF for less education in each region. Variability in 
prevalence estimates were due in part to variations in 
measurement (eg, in hearing loss) and in part due to the 
subjective nature of some assessments, such as physical 
activity. Details of the studies that were used to calculate 
the sensitivity analyses are shown in the appendix.
Discussion
To our knowledge, this study is the first to estimate the 
proportion of dementia cases that are attributable to nine 
risk factors (ie, the PAF) in LMICs. Overall PAFs for 
dementia were higher in China and India than our 
previous worldwide estimate of 35%, and higher still 
in our Latin American sample at 56%. The potential for 
prevention of dementia is therefore even greater in these 
countries than in higher-income countries. The highest 
PAF in each region was for less education in early life, but 
smoking, hypertension, obesity, and physical inactivity 
PAFs were also high, which highlights the potential 
priorities for prevention of dementia in these regions.
Dementia is more prevalent overall in India and Latin 
America than in developed countries (eg, the UK, when 
culturally appropriate screening tools are used), with 
prevalence estimates of 8·5% in India, 6·4% in China, 
and 8·6% in our Latin American sample,15 as compared 
with 6·4% in the EURODEM study16 of 11 European 
countries (to which the 10/66 data were directly 
standardised for age, sex, and education).
The estimation of PAFs are dependent on accurate 
prevalence data, which in turn are dependent on accurate 
measurement of a risk factor in the population. We did 
sensitivity analyses to identify whether alternative 
prevalence data changed our PAF estimates. We found 
that all regions had a similar or higher overall PAF than 
our previous worldwide estimates, even when the lowest 
prevalence figures were used, indicating the potential for 
greater targeting of dementia risk factors in these 
regions. In general, the prevalence estimates of low 
education, hypertension, obesity, and diabetes were 
higher than worldwide estimates across all three LMIC 
regions (although the diabetes estimate was similar to 
the US prevalence),10 leading to higher PAFs for all of 
these risk factors than previously calculated PAFs, which 
were mostly based on data from higher-income countries. 
The relative importance of each risk factor, as indicated 
by their individual PAF, also remained the same in most 
sensitivity estimates.
Previous estimates of the proportion of people with low 
education17 found that, in the 1960s, 57% of people older 
than 15 years in Latin America, 80·3% in south Asia, and 
68·5% in east Asia had no education or only completed 
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Overall weighted PAF ·· ·· ·· ·· 41·2% 
(39·1–43·4)
PAF=population attributable fraction. RR=relative risk. *Weighted PAF is the relative contribution of each risk factor to 
the overall PAF when adjusted for communality. 
Table 2: PAF for dementia risk factors in India (n=2004)
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Overall weighted PAF ·· ·· ·· ·· 55·8% 
(54·9–56·7)
PAF=population attributable fraction. RR=relative risk. *Weighted PAF is the relative contribution of each risk factor to 
the overall PAF when adjusted for communality. 
Table 3: PAF for dementia risk factors in the Latin American sample (n=12 865)
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primary school. The 10/66 population sample, who were 
65 years or older, would therefore have been older than 
15 years at the time these data were collected in the 1960s, 
and included in these schooling estimates. Estimates of 
low education from 2010 are lower in all regions than 
the data from the 1960s,17 which suggests that progress to 
improve education over the past 50 years might lead to a 
reduction in the prevalence of dementia, and the relative 
importance of this risk factor is likely to be lower for 
future generations than the present generation.
Lifecourse analysis is important, given that, for 
example, hypertension and obesity, which are risk 
factors in midlife, decrease as part of the development of 
dementia; therefore, tackling these risk factors in midlife 
years before the probable development of dementia is 
appropriate and important as a management strategy.18,19 
Although the 10/66 prevalence estimate might have 
included some people with later-life hypertension, it 
does not include those with undiagnosed hypertension 
or those who did not report their diagnosis. Sensitivity 
analyses based on other available prevalence estimates 
gave similar PAFs for all regions, indicating that 
hyper tension is an important potentially modifiable risk 
factor, and so public health programmes to increase 
identification and management of hypertension in 
midlife might reduce dementia prevalence.
Depression was relatively uncommon in China and 
India but more prevalent in Latin America than in 
higher-income countries. Our prevalence estimates for 
depression were similar to previous findings for India20 
and China,21 but for our Latin American sample were 
much higher than those reported in a WHO survey20 
(although only Mexico was included in their Latin 
American sample). Notably, the prevalence estimates for 
depression vary substantially between these regions 
(1·5% in China vs 23·9% in our Latin American sample), 
which is in keeping with a meta-analyses that showed a 
higher prevalence of depression in South America than 
in Asia.22 These results possibly reflect a true difference 
in prevalence. However, previous studies that made use 
of 10/66 data have highlighted that the low prevalence of 
depression reported in China might in part be due to 
contextual and cultural factors.23 If, as previous authors 
have suggested, the divergent prevalence of depression 
in these cultures reflect different cultural expressions 
of the same underlying depressive process, which 
is inadequately captured by traditional diagnostic ap-
proaches, then the PAF for depression in China might 
be an underestimate and the Latin American PAF might 
be an overestimate.
Social isolation was very uncommon in China and our 
Latin American sample, but in India was similar in 
prevalence to our UK estimates.2 This finding led to social 
isolation having the lowest PAF out of all the risk factors 
across the three regions, with a value of close to zero in 
China and our Latin American sample. In Health Survey 
England, 11% of people had less than monthly social 
contact.24 The higher amount of social support might be a 
strength of LMICs, and could be a useful model for how to 
build better connected communities in higher-income 
countries. Physical inactivity was more common in China 
and less common in India than worldwide estimates. Self-
reported prevalence of physical inactivity was also higher 
in all countries than estimates from other cross-sectional 
representative surveys,25 but lower than the studies in the 
sensitivity analyses,26,27 which could reflect the inaccuracy 
of self-reported activity.28
The prevalence of diabetes in the 10/66 surveys was 
similar to other cross-sectional surveys in India29 and 
China,30 but higher for Latin America.31 The PAF for 
diabetes was relatively low in all three regions, but the 
fact that, in previous surveys, almost 50% of people 
surveyed in India,29 nearly 40% in China,30 and 20% in 
Latin America32 were unaware that they had diabetes 
indicates that more needs to be done to diagnose and 
treat diabetes, to further mitigate any risk to dementia 
development it might pose.
Hearing loss prevalence was lower in China and India 
than worldwide estimates and our estimates from the 
UK.2 The 10/66 survey data only documented self-reported 
hearing impairment and not hearing impairment from 
audiometry, as done in cohort studies of hearing loss. 
Around two thirds of people with mild hearing loss and a 
third of those with severe hearing loss on audiometry 
report normal hearing.33 This might have led to an 
underestimate of hearing loss in the current study, given 
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Total adjusted for 
communality
·· ·· ·· ·· 35·0% 
(34·1–35·9)
Data were obtained from Livingston and colleagues.2 PAF=population attributable fraction. RR=relative risk. *Weighted 
PAF is the relative contribution of each risk factor to the overall PAF when adjusted for communality. 
Table 4: Worldwide PAFs for dementia risk factors
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that a substantial proportion of older people (aged 
≥65 years) with hearing loss are unaware of their 
impairment.34 Hearing loss has been previously classed 
as a midlife risk factor given that the lowest mean age of 
participants in studies that showed this link was 55 years. 
However, hearing loss is also a risk factor in adults aged 
65 years or older, and preliminary evidence suggests that 
hearing aid use can mitigate the risk of dementia from 
hearing loss, indicating some potential for prevention.35
To our knowledge, this study is the first to estimate 
PAFs for the widely accepted dementia risk factors in 
LMICs. We used data from a study whose methodology 
was identical in the eight countries it surveyed, making 
these figures comparable between countries. Our study 
has some limitations. Because the quality of the 
10/66 survey’s data on the prevalence of some risk factors, 
such as hearing loss, was uncertain, we did sensitivity 
analyses to model the potential effect of different risk 
factor prevalence estimates. The population sample was 
aged 65 years and older, so we could not measure midlife 
hypertension or obesity. We were also unable to measure 
exercise in midlife, but our calculations are based on the 
risk of physical inactivity in later life. The data relied on 
self-report for some of the risk factors, which is not ideal 
(eg, previous studies29,30,32 have shown that awareness of 
diabetes can be very low). Self-report is likely to have led to 
the underestimation of PAFs. Although 10/66 study 
participants had their blood pressure measured, we used 
self-report data, given that blood pressure might decrease 
in people who are developing dementia, which could lead 
to the under estimation of its prevalence. We did not use 
country-specific studies for risk associated with factors but 
rather available meta-analysis data, more of which 
was from higher-income countries than from LMICs. 
However, these meta-analysis-based estimates are likely to 
be more precise than individual studies in specific 
countries, given that they combine the findings from 
several studies, and they make the PAF more directly 
comparable with previous estimates.2 There is also no 
consistent evidence of gene–environment interaction with 
regard to dementia, which might cause the effect of a risk 
factor on dementia to vary globally.36–38 The causal direction 
underlying the association between these risk factors and 
dementia is uncertain, especially for associations found in 
later life. For example, depression might be a prodromal 
feature or a consequence rather than a cause of dementia.39 
Additionally, a PAF is a theoretical construct that assumes 
a reduction in risk on the basis of elimination of the 
risk factor. Risk factors are unlikely to be completely 
eliminated; however, reduction in risk factors is still likely 
to delay the onset of dementia, and thereby reduce the 
number of dementia cases.40 However, even a partial 
reduction in some of the factors could, at a population 
level, make an enormous difference in the future 
prevalence of dementia in LMICs, and we have indicated 
which factors could potentially have the largest effect. 
Finally, the data collected were recorded more than 
10 years ago, and the current prevalence of some risk 
factors might have changed. This limitation is, however, 
common within research that involves large amounts of 
data collection and periods of time between analyses.
Although overall numbers of people with dementia are 
increasing globally, the age-specific incidence and preva-
lence of dementia has reduced in many high-income 
countries over the past two decades.2,3,41 This reduction 
has been attributed to reduced frequency of dementia 
risk factors, particularly low education and cardiovascular 
risk, in successive generations of older people. Our study 
suggests that, because these risk factors are more 
common in Asia and Latin America, there is greater 
dementia prevention potential in these LMICs than in 
high-income countries. Low education, hearing loss, 
obesity, and physical activity had particularly high PAFs 
and so might be initial targets for policy makers devising 
dementia prevention strategies. Public health strategies 
are likely to need to be specific to the setting in which 
they are used, and future research should establish 
whether such strategies affect the prevalence of risk 
factors and subsequent dementia prevalence. As 
dementia is forecast to become the leading public health 
challenge globally, capitalising on the potential for 
prevention is an urgent priority.
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